Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tanis

Showing results (411-420 of 429) with videos related to

Pageof 43
Sort By:
JNCI Cancer Spectrum|December 15, 2025
Physical activity patterns after diagnosis and survival of prognostic colorectal cancer subgroupsKarel C Smit, Jeroen W G Derksen, Anne-Sophie van Lanen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectumCornelis J H van de Velde, Petra G Boelens, Josep M Borras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2024
Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer GroupD E W van der Kruijssen, S G Elias, P M van de Ven, et al.
BMC Cancer|May 19, 2026
A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trialE Banken, M Borg, I E G van Hellemond, et al.
BMC Cancer|May 25, 2015
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trialCharlotte E L Klaver, Gijsbert D Musters, Willem A Bemelman, et al.
The Lancet. Oncology|June 29, 2026
Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trialKoen P Rovers, Checca Bakkers, Teun B M van den Heuvel, et al.
Nature Communications|August 4, 2022
Molecular characterization of colorectal cancer related peritoneal metastatic diseaseKristiaan J Lenos, Sander Bach, Leandro Ferreira Moreno, et al.
JAMA Surgery|May 19, 2021
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical TrialKoen P Rovers, Checca Bakkers, Simon W Nienhuijs, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 26, 2019
Implementation and outcome of minor and major minimally invasive liver surgery in the NetherlandsMarcel J van der Poel, Robert S Fichtinger, Marc Bemelmans, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 17, 2022
Protective ileostomy creation after anterior resection of the rectum: Shared decision-making or still subjective?Andrea Balla, Federica Saraceno, Marika Rullo, et al.
Pageof 43

Showing results (411-420 of 429) with videos related to

Sort By:
Pageof 43
JNCI Cancer Spectrum|December 15, 2025
Physical activity patterns after diagnosis and survival of prognostic colorectal cancer subgroupsKarel C Smit, Jeroen W G Derksen, Anne-Sophie van Lanen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectumCornelis J H van de Velde, Petra G Boelens, Josep M Borras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2024
Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer GroupD E W van der Kruijssen, S G Elias, P M van de Ven, et al.
BMC Cancer|May 19, 2026
A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trialE Banken, M Borg, I E G van Hellemond, et al.
BMC Cancer|May 25, 2015
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trialCharlotte E L Klaver, Gijsbert D Musters, Willem A Bemelman, et al.
The Lancet. Oncology|June 29, 2026
Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trialKoen P Rovers, Checca Bakkers, Teun B M van den Heuvel, et al.
Nature Communications|August 4, 2022
Molecular characterization of colorectal cancer related peritoneal metastatic diseaseKristiaan J Lenos, Sander Bach, Leandro Ferreira Moreno, et al.
JAMA Surgery|May 19, 2021
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical TrialKoen P Rovers, Checca Bakkers, Simon W Nienhuijs, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 26, 2019
Implementation and outcome of minor and major minimally invasive liver surgery in the NetherlandsMarcel J van der Poel, Robert S Fichtinger, Marc Bemelmans, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 17, 2022
Protective ileostomy creation after anterior resection of the rectum: Shared decision-making or still subjective?Andrea Balla, Federica Saraceno, Marika Rullo, et al.
Pageof 43